Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease--an ECCO-EpiCom study
Language English Country Great Britain, England Media print-electronic
Document type Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
PubMed
24560877
DOI
10.1016/j.crohns.2014.01.028
PII: S1873-9946(14)00047-6
Knihovny.cz E-resources
- Keywords
- Disease course, Epidemiology;, Inception cohort;, Quality of life;,
- MeSH
- Digestive System Surgical Procedures methods MeSH
- Adult MeSH
- Inflammatory Bowel Diseases epidemiology psychology therapy MeSH
- Quality of Life * MeSH
- Middle Aged MeSH
- Humans MeSH
- Disease Management * MeSH
- Adolescent MeSH
- Young Adult MeSH
- Morbidity trends MeSH
- Follow-Up Studies MeSH
- Prognosis MeSH
- Prospective Studies MeSH
- Surveys and Questionnaires MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Population Surveillance * MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Europe epidemiology MeSH
BACKGROUND & AIMS: Health-related quality of life (HRQoL) is impaired in patients with Inflammatory Bowel Disease (IBD). The aim was prospectively to assess and validate the pattern of HRQoL in an unselected, population-based inception cohort of IBD patients from Eastern and Western Europe. METHODS: The EpiCom inception cohort consists of 1560 IBD patients from 31 European centres covering a background population of approximately 10.1 million. Patients answered the disease specific Short Inflammatory Bowel Disease Questionnaire (SIBDQ) and generic Short Form 12 (SF-12) questionnaire at diagnosis and after one year of follow-up. RESULTS: In total, 1079 patients were included in this study. Crohn's disease (CD) patients mean SIBDQ scores improved from 45.3 to 55.3 in Eastern Europe and from 44.9 to 53.6 in Western Europe. SIBDQ scores for ulcerative colitis (UC) patients improved from 44.9 to 57.4 and from 48.8 to 55.7, respectively. UC patients needing surgery or biologicals had lower SIBDQ scores before and after compared to the rest, while biological therapy improved SIBDQ scores in CD. CD and UC patients in both regions improved all SF-12 scores. Only Eastern European UC patients achieved SF-12 summary scores equal to or above the normal population. CONCLUSION: Medical and surgical treatment improved HRQoL during the first year of disease. The majority of IBD patients in both Eastern and Western Europe reported a positive perception of disease-specific but not generic HRQoL. Biological therapy improved HRQoL in CD patients, while UC patients in need of surgery or biological therapy experienced lower perceptions of HRQoL than the rest.
1st Department of Medicine Semmelweis University Budapest Hungary
Clinic of Gastroenterology University of Medicine 'Victor Babes' Timisoara Romania
Department of Gastroenterology Adelaide and Meath Hospital TCD Dublin Ireland
Department of Gastroenterology Moscow Regional Research Clinical Institute Moscow Russian Federation
Department of Medical Gastroenterology Gentofte Hospital Copenhagen Denmark
Department of Medical Gastroenterology Odense University Hospital Odense Denmark
Department of Medicine 5 Hepatology and Gastroenterology Aarhus University Hospital Aarhus Denmark
Department of Medicine Amager Hospital Amager Denmark
Department of Medicine Csolnoky F Province Hospital Veszprem Hungary
Department of Medicine Division of Gastroenterology Örebro University Hospital Örebro Sweden
Department of Medicine Herning Central Hospital Herning Denmark
Digestive Disease Centre Medical Section Herlev University Hospital Copenhagen Denmark
Division of Endocrinology and Gastroenterology Tartu University Hospital Tartu Estonia
Gastroenterology Department Complexo Hospitalario Universitario de Vigo Vigo Spain
Gastroenterology Department Hospital České Budějovice České Budějovice Czech Republic
Gastroenterology Department POVISA Hospital Vigo Spain
Hospital de Vale de Sousa Porto Portugal
IBD Center ISCARE Charles University Prague Czech Republic
Institute for Digestive Research Lithuanian University of Health Sciences Kaunas Lithuania
Medical Department Dronning Ingrids Hospital Nuuk Greenland
Medical Department The National Hospital of the Faroe Islands Torshavn Faroe Islands
Medical Department Viborg Regional Hospital Viborg Denmark
Nicosia Private Practice Nicosia Cyprus
References provided by Crossref.org